XML 46 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Depreciation $ 235      
Research And Development Cost $ 185,653 $ 29,185 $ 375,032 $ 57,718
Antidilutive Excluded From Computation Of Earnings Per Share, Shares 12,660,000      
Allowance for doubtful accounts     0 0
Cash equivalents     0 0
Uncertain tax positions     0 0
Loss on impairment     $ 0 $ 0
Warrant [Member]        
Antidilutive Excluded From Computation Of Earnings Per Share, Shares     12,596,000 1,363,350